A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin. [electronic resource]
Producer: 20151113Description: 797-801 p. digitalISSN:- 1435-702X
- Acute Disease
- Adolescent
- Adult
- Demyelinating Diseases -- diagnosis
- Double-Blind Method
- Drug Therapy, Combination
- Erythropoietin -- therapeutic use
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Infusions, Intravenous
- Male
- Methylprednisolone -- therapeutic use
- Nerve Fibers -- pathology
- Optic Neuritis -- diagnosis
- Recombinant Proteins -- therapeutic use
- Retinal Ganglion Cells -- pathology
- Tomography, Optical Coherence
- Visual Acuity
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.